$11.72
-0.24-2.01%
At Close: -
$11.93
0.211.79%
After Hours: Sep 11, 5:21 AM EDT
15 minutes delayed
Comments
Loading...
Abivax (NASDAQ:ABVX) Stock, Analyst Ratings, Price Targets, Forecasts
Abivax SA has a consensus price target of $36.5 based on the ratings of 6 analysts. The high is $50 issued by Guggenheim on April 29, 2024. The low is $16 issued by Morgan Stanley on April 11, 2024. The 3 most-recent analyst ratings were released by Laidlaw & Co., BTIG, and Guggenheim on July 29, 2024, May 20, 2024, and April 29, 2024, respectively. With an average price target of $47 between Laidlaw & Co., BTIG, and Guggenheim, there's an implied 293.96% upside for Abivax SA from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Laidlaw & Co.
BTIG
Guggenheim
Piper Sandler
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Abivax
Data brought to you by Benzinga APIs
FAQ
What is the target price for Abivax (ABVX) stock?
The latest price target for Abivax (NASDAQ:ABVX) was reported by Laidlaw & Co. on July 29, 2024. The analyst firm set a price target for $48.00 expecting ABVX to rise to within 12 months (a possible 302.35% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Abivax (ABVX)?
The latest analyst rating for Abivax (NASDAQ:ABVX) was provided by Laidlaw & Co., and Abivax initiated their buy rating.
When was the last upgrade for Abivax (ABVX)?
There is no last upgrade for Abivax
When was the last downgrade for Abivax (ABVX)?
There is no last downgrade for Abivax.
When is the next analyst rating going to be posted or updated for Abivax (ABVX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abivax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abivax was filed on July 29, 2024 so you should expect the next rating to be made available sometime around July 29, 2025.
Is the Analyst Rating Abivax (ABVX) correct?
While ratings are subjective and will change, the latest Abivax (ABVX) rating was a initiated with a price target of $0.00 to $48.00. The current price Abivax (ABVX) is trading at is $11.93, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.